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Abstract Array-based comparative genomic hybridiza-
tion (a-CGH) is a promising tool for clinical genomic stud-
ies. However, pre-analytical sample preparation methods
have not been fully evaluated for this purpose. Parallel sec-
tions of normal male human skin biopsy samples were col-
lected and immediately immersed in saline, formalin and a
molecular Wxative for 8, 12 and 24 h. Genomic DNA was
isolated from the samples and subjected to ampliWcation
and labeling. Labeled samples were then co-hybridized
with normal reference female DNA to Agilent oligonucleo-
tide-based a-CGH 44k slides. Pre-analytic parameters such
as DNA yield, quality of genomic DNA and labeling
eYcacy were evaluated. Also microarray analytical vari-
ables, including the feature signal intensity, data distribu-
tion dynamic range, signal to noise ratio and background
intensity levels were assessed for data quality. DNA yield
and quality of genomic DNA—as evaluated by spectropho-
tometry and gel electrophoresis—were similar for fresh and
molecular Wxative-exposed samples. In addition, labeling
eYcacy of dye incorporation was not drastically diVerent.
There was no diVerence between fresh and molecular Wxa-
tive material comparing scan parameters and stem plot
analysis of a-CGH result. Formalin-Wxed samples, on the
other hand, showed various errors such as oversaturation,
non-uniformity in replicates, and decreased signal to noise
ratio. Overall, the a-CGH result of formalin samples was
not interpretable. DNA extracted from formalin-Wxed tissue
samples is not suitable for oligonucleotide-based a-CGH
studies. On the other hand, the molecular Wxative preserves
tissue DNA similar to its fresh state with no discernable
analytical diVerences.
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Introduction
Applications of new technologies have resulted in major
advancements in laboratory medicine [1]. Bringing these
advances into clinical practice, however, requires careful
evaluation and validation. Array-based comparative geno-
mic hybridization (a-CGH) is an extremely powerful tool
that can generate high resolution mapping of chromosomal
abnormalities. Advances in microarray technology and bio-
informatics have now made a-CGH easily available and
aVordable [14,  15]. With a-CGH’s potential for clinical
application, it is important that guidelines for proper sam-
ple preparation and control of quality are developed. Since
conventional methods of clinical tissue preparation com-
monly employ formalin Wxation, we studied the suitability
of formalin for array CGH studies and compared the results
to that of clinical samples that were preserved in a newly
developed, molecular-friendly Wxative.
The study was approved by the University of Miami
Institutional Review Board. Three separate normal skin
biopsies from one volunteer healthy male were immedi-
ately sliced in three parts each 0.1 £ 0.2 £ 0.2 cm. One
part was immersed in normal saline solution, one part in a
methanol-based molecular tissue Wxative, UMFIX (Universal
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Molecular Fixative, marketed as Tissue-Tek® Xpress™
Molecular Fixative, Sakura Finetek, Torrance, CA), and the
third slice was Wxed in 10% neutral buVered formalin.
Volume of Wxative/preservative was 150 ml and incubation
was performed at room temperature. After 8 (set 1), 12 (set 2)
and 24 h (set 3), the genomic DNA was extracted from the
samples using Puregene DNA PuriWcation System tissue kit
(Gentra, Minneapolis, MN). One microliter of extracted
DNA solution was diluted in Tris–EDTA (TE) buVer and
evaluated on ND-1000 spectrophotometer (NanoDrop Tech-
nologies, Rockland, DE). Gel electrophoresis (0.8% agarose
gel) was performed to evaluate the quality of genomic DNA.
DNA yield and quality of genomic DNA as evaluated by
spectrophotometry, were similar between the samples
(Table 1), although UMFIX samples appeared to have bet-
ter quality. A260/A280 ratio determines presence of con-
taminating proteins and a ratio of more than 1.8 is generally
considered to be indicative of high quality sample. All
UMFIX samples consistently had a ratio of more than 1.8.
We further evaluated the quality of DNA by agarose gel
electrophoresis that showed presence of high molecular
weight (HMW) genomic DNA band in all samples
(Fig. 1a). While formalin-Wxed sample showed higher deg-
radation and lower intensity of genomic DNA, UMFIX-
exposed samples did not appear degraded.
Genomic DNA from the skin samples and the control
female DNA (Promega, Madison, WI) were then subjected
to ampliWcation according to Agilent’s (Palo Alto, CA) pro-
tocol for oligonucleotide array-based CGH for genomic
DNA (version 2.0 August 2005). AmpliWcation, of both
male genomic DNA and female control DNA, 100 ng each,
was performed using Qiagen REPLI-g AmpliWcation Kit.
AmpliWed DNA was digested during a 2 h incubation at
37°C, with Alu I and Rsa I (10 U/l; 5l/reaction) restric-
tion enzymes (Promega, Madison, WI). PuriWcation of
digested DNA was performed with QIAprep Spin Miniprep
Kit (Qiagen, Valencia, CA). Digested DNA was subjected
to electrophoresis to evaluate quality of ampliWed DNA by
visual inspection of its uniformity and range.
Table 1 Spectrophotometric 
result of total DNA yield, DNA 
purity, and labeling eYciency, 
for fresh, formalin-Wxed and 
UMFIX-exposed samples
Sample Total DNA 
(g)
A260/A280 A260/A230 Sample-cy5 labeling 
eYciency (pmol/g)
Control-cy3 labeling 
eYciency (pmol/g)
Fresh 1 3.89 1.77 1.43 70.8 111
Fresh 2 2.94 1.86 1.79 42.8 89.6
Fresh 3 2.93 1.9 2 52.8 97
Mean § SD 3.25 § 0.55 1.84 § 0.07 1.74 § 0.29 55.47 § 14.19 99.20 § 10.87
UMFIX 1 6.416 1.85 2 78.6 110
UMFIX 2 2.7138 1.86 1.84 49.6 88
UMFIX 3 4.012 1.86 1.8 48.2 81.8
Mean § SD 4.38 § 1.88 1.86 § 0.01 1.88 § 0.11 58.80 § 17.16 93.27 § 14.82
Formalin 1 5.366 1.58 0.84 59.8 142.4
Formalin 2 4.0424 1.67 1.11 41.2 73.4
Formalin 3 4.427 1.93 2.08 36.2 77.4
Mean § SD 4.61 § 0.68 1.73 § 0.18 1.34 § 0.65 45.73 § 12.44 97.73 § 38.73 1 8h ,   2 12 h, 3 24 h
Fig. 1 Result of gel electrophoresis for genomic DNA a HMW geno-
mic DNA is visible in all samples. There is more DNA degradation in
formalin-Wxed samples. b Formalin-Wxed samples do not show uni-
form strong smear after linear ampliWcation. c PCR for GAPDH shows
a 450 bp amplicon in all samples with a lesser intensity in formalin-
Wxed samples, L ladder (numbers indicate bp), S fresh control in saline,
U UMFIX, F formalin, P positive control, N negative controlArch Dermatol Res (2007) 299:353–357 355
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The ampliWcation eYciency of DNA from formalin-
Wxed samples was less than fresh and UMFIX samples, as
evidenced by the size and Xuorescent intensity of the bands
(Fig. 1b).
We also used PCR for GAPDH primers to gauge the
quality of extracted DNA. PCR was performed using glyc-
eraldehyde-3-phosphate dehydrogenase primers (GAPDH,
Clonetech, Palo Alto, CA) using 0.5 g of RNase-treated
isolated DNA and Qiagen TaqPCR Mastermix (Qiagen,
Valencia, CA). The conditions for DNA PCR were as fol-
lows: 95°C, 15 min; 35 cycles at 94°C, 45 s; 60°C, 45 s;
72°C, 2 min. As seen in Fig. 1c, a 450 bp band was
detected in all samples, although the intensity was consid-
erably lower in formalin-Wxed material.
AmpliWed Genomic DNA was then labeled using Bio-
Prime Array CGH Genomic Labeling kit (Invitrogen,
Carlsbad, CA). Quality analysis and quantitation was
performed with ND-1000 (NanoDrop Technologies, Wil-
mington, DE) spectrophotometer to calculate the labeling
eYciency. Labeled and puriWed samples were combined
with hybridization master mix and applied to Agilent
Human Genome CGH Microarray 44B slides for 40 h at
65°C. To minimize the impact of environmental oxidants
on signal intensities, slides were scanned immediately
using Agilent microarray scanner 4800B. Array images
were analyzed using Agilent feature extraction software
(v8.1) and CGH explorer (v2.51) [9]. Microarray analyti-
cal variables, including the feature signal intensity, data
distribution dynamic range, signal to noise ratio and
background intensity levels, and the number of saturated
and undetected features was used to assess microarray
quality.
One of the steps in microarray quality control is labeling
eYcacy or dye incorporation. Dye incorporation was not
drastically diVerent between fresh and UMFIX-exposed
samples but formalin-Wxed samples showed less dye incor-
poration (Table 1). There were no diVerences between fresh
and UMFIX-exposed material with regard to scan parame-
ters (Table 2). Formalin-Wxed samples, showed various
errors such as over-saturation, non-uniformity in replicates
and increased signal to noise ratio. The numbers of non-
uniform features were at least ten fold higher in formalin-
Wxed samples. The signal to noise ratio of replicated probes
can be used to evaluate reproducibility of signals. Forma-
lin-Wxed samples showed a higher median %CV value,
indicating lower reproducibility of signal across the micro-
array and lower signal to noise ratio. The number of fea-
tures that were saturated in the scanned image was also
signiWcantly higher in formalin-Wxed samples.
These Wndings may be attributed to erratic and random
fragmentation of DNA in formalin-Wxed samples. The frag-
mentation itself results in increase background noise and
aberrant signal intensity due to random hybridization.
We further analyzed array scan data by a-CGH explorer
software using stem-plot analysis for moving averages.
Fresh and UMFIX-exposed sample showed a readable plot
with the expected diVerence in XY chromosome regions; as
expected from the female control and male samples. Also,
they showed reproducibly ampliWed and deleted region in
our test sample DNA. A-CGH result from formalin-Wxed
samples was not interpretable (Fig. 2).
Array CGH studies have great potential for clinical
application. Since the technique does not utilize live cells, it
is considerably more advantageous when compared to con-
ventional karyotyping techniques. Array CGH has its own
limitations, such as failure to detect translocations; never-
theless it oVers unprecedented spatial resolution [6,  11].
Recently, it has been shown that low-level gene copy num-
ber change is associated with changes in expression level of
its transcripts [12]. Therefore, results of transcriptomics
Table 2 Representative data 
of microarray scan quality 
measurement
Sample Non-uniform feature Reproducibility: non-control 
replicated probes median %CV
Saturated feature
Red Green Red Green Red Green
Fresh 1 113 379 7 8 0 1
Fresh 2 51 139 4 4 0 0
Fresh 3 38 135 5 6 0 0
Mean § SD 67 § 40 218 § 140 5 § 16 § 20 0
UMFIX 1 352 560 13 13 0 0
UMFIX 2 85 179 7 8 0 0
UMFIX 3 36 136 6 7 0 0
Mean § SD 158 § 170 292 § 233 8 § 49 § 30 0
Formalin 1 1,402 302 77 6 285 1
Formalin 2 1,987 157 37 12 361 0
Formalin 3 3,135 170 94 8 326 0
Mean § SD 2,175 § 882 210 § 80 69 § 30 9 § 33 2 4 § 38 0
Red cy5 labeled samples, green 
cy3 labeled controls, 1 8h ,   2 
12 h, 3 24 h356 Arch Dermatol Res (2007) 299:353–357
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studies can be used to study DNA markers, which are more
stable and easier to study than RNA.
Array GGH was originally based on BAC (Bacterial
ArtiWcial Chromosomes), but more recently it utilizes oli-
gonucleotides, with its ability to provide whole genome-
covering resolution. Synthetic oligonucleotides obviously
have the advantage because their exact sequence and length
are known for each element on the array. Oligonucleotide
array CGH (oa-CGH) has the beneWt of overcoming the
diYculties inherent to BAC arrays, such as the amount of
available DNA, clone management, probe identity due to
PCR contaminations, and mapping inaccuracies. Using oa-
CGH, it is also possible to eliminate another source of
error, which is the batch-to-batch variability of Cot-1 DNA,
used to block repetitive DNA sequences, since the oligonu-
cleotide probes are designed to be repeat-free [20].
Samples used in nearly all a-CGH studies have been
fresh or fresh-frozen tissue. Such material, although useful
in research settings, is impractical and cumbersome to use
in clinical practice. Furthermore, because diagnostic biopsy
samples are relatively small, the amount of residual tissue
for additional ancillary testing may be inadequate. Hence
there is a great need to develop test strategies that require
minimal amounts of tissue and are robust enough to with-
stand pre-analytical sample preparation. SimpliWed
schemes for sample preservation that allow reliable histo-
morphology along with preservation of high quality macro-
molecules are desirable.
We have previously described a novel tissue Wxation and
processing technique that beside providing adequate histo-
morphology also preserves high quality HMW RNA, akin
to fresh samples [19]. This Wxative also protects HMW tis-
sue DNA for use in PCR studies [18]. Here, we further
evaluated the suitability of skin tissue DNA for array CGH
studies using same methods applied routinely for fresh
samples. This study demonstrates that using the novel Wxa-
tive it is possible to preserve and extract high molecular
weight genomic DNA, supported by high labeling
eYciency, comparable to that from fresh tissue. Further-
more, no artifacts were seen using this DNA in microarray
scanning or analysis for array CGH.
Array CGH studies have been performed on formalin-
Wxed tissues with variable and irreproducible results. Most
of the prior studies were based on low-resolution BAC
arrays without detailed description of DNA quality or array
metrics [10, 21]. Besides, there was often inadequate docu-
mentation of Wxation time, the volumetric ratio of Wxative
to tissue, or buVering status. Only few studies have ade-
quately addressed analytical aspects of Wxation and pro-
cessing on array CGH. Ghazani et al. [4] studied the eVect
of formalin Wxation on MCF-7 cell line and on one breast
cancer tissue sample. They used two diVerent BAC clone
arrays; 1.7k for the cell line and 19k for the breast cancer
sample [4]. There was no mention of Wxative volume or
quality of genomic DNA. They showed that long term
(1 week) Wxation results in extensive loss of HMW DNA.
In cell lines, the concordance between fresh and formalin-
Wxed samples was around 85%. When genomic DNA was
ampliWed, the concordance decreased to 75%.
Johnson et al. [5] also studied the eVect of formalin Wxa-
tion on a-CGH using BAC arrays. Our results support their
conclusion that analysis of DNA samples on agarose gels
does not oVer any advantage in prediction of suitability of
formalin-Wxed tissue samples for a-CGH. They also show
that the quality of a-CGH depends on the integrity of DNA
samples with the requirement that extracted DNA supports
the PCR ampliWcation of an amplicon of 300 bp or longer.
We showed that it is possible to detect amplicons of up to
450 bp in formalin-Wxed sample; (albeit with lower inten-
sity when compared to fresh or UMFIX-exposed samples).
The studies by Johnson and others show the possibility of
having acceptable results with DNA from formalin-Wxed
samples using BAC arrays but there are no data that sup-
ports its suitability for oa-CGH arrays. This may be due to
Fig. 2 Array CGH stem plot of 8-h preserved skin samples—chromo-
somes are displayed on x-axis and relative ratios on y-axis. Green (con-
trol XX female, Cy3 labeled) Red (test XY male, Cy5 labeled). X and
Y chromosomes are markedArch Dermatol Res (2007) 299:353–357 357
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larger sequence of probes presented in BAC array. Other
investigators have shown that using alternative approaches
to DNA extraction, quantiWcation, ampliWcation or labeling
may produce improved results. However, all other authors
do agree that the procedures for improving DNA quality are
neither substitute for high quality DNA nor they could
obtain consistent results from formalin-Wxed samples [7,
10]. This is mostly due to complex chemical eVect of for-
malin on tissue, which is still poorly understood. Formalin
has a tissue penetration rate of 2.4 mm in 24 h and adequate
Wxation requires at least a ten to one volumetric ratio of
Wxative to tissue [3]. Therefore, many clinical specimens
are only partially Wxed by formalin before processing. Fur-
thermore during processing, they are exposed to formalin
and alcohol, introducing formalin and alcohol-related tissue
artifacts [13]. Formaldehyde is a dipolar molecule and can
react with amino, or imino group of the anionic forms of
the amino acids. This reaction is time and temperature
dependent [2, 9, 16, 17, 18]. More recent Wndings show that
the deleterious eVect of formalin Wxation might also result
from cumulative action of other reagents and processing
conditions. Conversely, no DNA or nucleoside reactions
have been reported with ethanol and none would be
expected under physiological conditions [8]. By changing
the three dimensional structure of the proteins, alcohols
prevent protein functions. Therefore, rapid Wxation of sam-
ples prevents alteration and degradation of biomolecules
and preserves them in their native form [11].
In summary, we show that by using a new molecular
Wxative it is possible to preserve skin tissue DNA that is
suitable for array CGH studies; identical to fresh tissue.
This can be achieved using same methods and protocols
used for fresh samples.
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